Work

Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.5046

Authors: T. E. Hutson, I. D. Davis, J. H. Machiels, P. L. de Souza, K. Baker, W. Bordogna, R. Westlund, T. Crofts, L. Pandite, R. A. Figlin

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2337968495

Cites:

Cited by: 82

Related to: 10